'Bohemian Rhapsody' of MR1T cells

Affiliations

¹ Experimental Immunology, Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland. lucia.mori@unibas.ch.
² Experimental Immunology, Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.

Comment

Lucia Mori et al. Nat Immunol. 2020 Feb.

. 2020 Feb;21(2):108-110.

doi: 10.1038/s41590-019-0588-6.

¹ Experimental Immunology, Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland. lucia.mori@unibas.ch.
² Experimental Immunology, Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.

No abstract available

Comment on

Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1.
Crowther MD, Dolton G, Legut M, Caillaud ME, Lloyd A, Attaf M, Galloway SAE, Rius C, Farrell CP, Szomolay B, Ager A, Parker AL, Fuller A, Donia M, McCluskey J, Rossjohn J, Svane IM, Phillips JD, Sewell AK. Crowther MD, et al. Nat Immunol. 2020 Feb;21(2):178-185. doi: 10.1038/s41590-019-0578-8. Epub 2020 Jan 20. Nat Immunol. 2020. PMID: 31959982 Free PMC article.

1. Crowther, M. D. et al. Nat. Immunol. https://doi.org/10.1038/s41590-019-0578-8 (2019). - DOI
1. Porcelli, S., Yockey, C. E., Brenner, M. B. & Balk, S. P. J. Exp. Med. 178, 1–16 (1993). - DOI
1. Tilloy, F. et al. J. Exp. Med. 189, 1907–1921 (1999). - DOI
1. Treiner, E. et al. Nature 422, 164–169 (2003). - DOI
1. Reantragoon, R. et al. J. Exp. Med. 210, 2305–2320 (2013). - DOI